Dr. David Arterburn explains reassuring findings about the nation's most widely used anti-obesity drug.
Dr. Gregory Simon says research is needed to see if this new drug for persistent depression will prevent suicides.
With $10 million from NIMH, KPWHRI is leading a multi-site study to ensure safe prescribing of antipsychotic drugs for youth with behavioral disorders.
For over a decade, Dr. Michael Von Korff and others have been working on a strategy to stop the opioid epidemic. Here’s an outline.
A GHRI researcher worries about easy access to prescription meds after seeing for herself how common they are across the border.
